These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 3233054)

  • 1. Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats.
    Dzoljic ED; Kaplan CD; Dzoljic MR
    Arch Int Pharmacodyn Ther; 1988; 294():64-70. PubMed ID: 3233054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ibogaine fails to reduce naloxone-precipitated withdrawal in the morphine dependent rat.
    Sharpe L; Jaffe J
    NIDA Res Monogr; 1990; 105():477. PubMed ID: 1876088
    [No Abstract]   [Full Text] [Related]  

  • 3. Ibogaine fails to reduce naloxone-precipitated withdrawal in the morphine-dependent rat.
    Sharpe LG; Jaffe JH
    Neuroreport; 1990 Sep; 1(1):17-9. PubMed ID: 2129850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ibogaine on naloxone-precipitated withdrawal in morphine-dependent mice.
    Francés B; Gout R; Cros J; Zajac JM
    Fundam Clin Pharmacol; 1992; 6(8-9):327-32. PubMed ID: 1292965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enkephalinase inhibition suppresses naloxone-induced jumping in morphine-dependent mice.
    Dzoljic MR; Rademaker B; vd Poel-Heisterkamp AL; Ukponmwan OE; Haffmans J
    Arch Int Pharmacodyn Ther; 1986 Oct; 283(2):222-8. PubMed ID: 3539055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
    Neal BS; Sparber SB
    J Pharmacol Exp Ther; 1986 Jan; 236(1):157-65. PubMed ID: 3001281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
    Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
    Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory effect of norharman on morphine withdrawal syndrome in rats: comparison with ibogaine.
    Cappendijk SL; Fekkes D; Dzoljic MR
    Behav Brain Res; 1994 Nov; 65(1):117-9. PubMed ID: 7880450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibogaine interferes with motivational and somatic effects of naloxone-precipitated withdrawal from acutely administered morphine.
    Parke LA; Burton P; McDonald RV; Kim JA; Siegel S
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):293-7. PubMed ID: 11817506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA antagonist properties of the putative antiaddictive drug, ibogaine.
    Popik P; Layer RT; Fossom LH; Benveniste M; Geter-Douglass B; Witkin JM; Skolnick P
    J Pharmacol Exp Ther; 1995 Nov; 275(2):753-60. PubMed ID: 7473163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score".
    Fdez Espejo E; Cador M; Stinus L
    Psychopharmacology (Berl); 1995 Nov; 122(2):122-30. PubMed ID: 8848527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of spontaneous morphine withdrawal symptoms in rats.
    van der Laan JW; van 't Land CJ; Loeber JG; de Groot G
    Arch Int Pharmacodyn Ther; 1991; 311():32-45. PubMed ID: 1789712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central sites of naloxone-precipitated shaking in the anesthetized, morphine-dependent rat.
    Wei E; Sigel SS; Loh HH; Way EL
    J Pharmacol Exp Ther; 1975 Dec; 195(3):480-7. PubMed ID: 1238555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive mechanism and acute and chronic behavioral effects of clonidine.
    Aceto MD; Harris LS
    Prog Clin Biol Res; 1981; 71():243-58. PubMed ID: 6276896
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal.
    Higgins GA; Nguyen P; Joharchi N; Sellers EM
    Psychopharmacology (Berl); 1991; 105(3):322-8. PubMed ID: 1839177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intragastric agmatine on morphine-induced physiological dependence in beagle dogs and rhesus monkeys.
    Su RB; Lu XQ; Huang Y; Liu Y; Gong ZH; Wei XL; Wu N; Li J
    Eur J Pharmacol; 2008 Jun; 587(1-3):155-62. PubMed ID: 18455724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking naloxone-precipitated withdrawal in rats and hamsters.
    Schnur P; Espinoza M; Flores R; Ortiz S; Vallejos S; Wainwright M
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1093-8. PubMed ID: 1475293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of precipitated abstinence in methadone-dependent rats by delta 9-THC.
    Hine B; Torrelio M; Gershon S
    Psychopharmacol Commun; 1975; 1(3):275-83. PubMed ID: 1241452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.